Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.50
-0.50 (-4.76%)
Jun 13, 2025, 4:35 PM GMT+1
Ondine Biomedical Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 9.77 | 2.98 | 13.13 | 30.37 | 0.63 | Upgrade
|
| Cash & Short-Term Investments | 9.77 | 2.98 | 13.13 | 30.37 | 0.63 | Upgrade
|
| Cash Growth | 227.64% | -77.29% | -56.78% | 4750.64% | -28.58% | Upgrade
|
| Accounts Receivable | 0.46 | 0.32 | 0.13 | 0.16 | 0.54 | Upgrade
|
| Other Receivables | 0.06 | 0 | 0.05 | 0.09 | 0.01 | Upgrade
|
| Receivables | 0.51 | 0.33 | 0.18 | 0.25 | 0.54 | Upgrade
|
| Inventory | 1.27 | 1.07 | 1.29 | 1.06 | 0.4 | Upgrade
|
| Prepaid Expenses | 0.48 | 0.22 | 0.38 | 1.83 | 0.17 | Upgrade
|
| Restricted Cash | 0.16 | 0.16 | 0.15 | - | - | Upgrade
|
| Total Current Assets | 12.19 | 4.75 | 15.13 | 33.5 | 1.75 | Upgrade
|
| Property, Plant & Equipment | 0.6 | 0.95 | 1.4 | 0.6 | 0.67 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.17 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | Upgrade
|
| Total Assets | 12.82 | 5.73 | 16.57 | 34.14 | 2.64 | Upgrade
|
| Accounts Payable | 1.59 | 1.36 | 0.39 | 1.2 | 0.77 | Upgrade
|
| Accrued Expenses | 4.19 | 1.75 | 3.16 | 2.08 | 0.64 | Upgrade
|
| Short-Term Debt | - | - | - | - | 26.99 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 7.16 | Upgrade
|
| Current Portion of Leases | 0.17 | 0.38 | 0.36 | 0.15 | 0.23 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.5 | - | Upgrade
|
| Total Current Liabilities | 5.95 | 3.49 | 3.91 | 3.92 | 35.79 | Upgrade
|
| Long-Term Debt | - | - | 0.48 | 0.47 | 0.59 | Upgrade
|
| Long-Term Leases | - | 0.16 | 0.54 | 0.09 | 0.09 | Upgrade
|
| Total Liabilities | 5.95 | 3.65 | 4.93 | 4.48 | 36.46 | Upgrade
|
| Common Stock | 262.6 | 239.65 | 235.04 | 235.04 | 119.53 | Upgrade
|
| Additional Paid-In Capital | 10.53 | 10.53 | 10.53 | 10.53 | 10.38 | Upgrade
|
| Retained Earnings | -285.43 | -266.33 | -251.92 | -232.54 | -182.14 | Upgrade
|
| Comprehensive Income & Other | 19.18 | 18.24 | 18 | 16.64 | 18.42 | Upgrade
|
| Total Common Equity | 6.88 | 2.09 | 11.64 | 29.66 | -33.81 | Upgrade
|
| Minority Interest | - | - | - | - | -0.01 | Upgrade
|
| Shareholders' Equity | 6.88 | 2.09 | 11.64 | 29.66 | -33.83 | Upgrade
|
| Total Liabilities & Equity | 12.82 | 5.73 | 16.57 | 34.14 | 2.64 | Upgrade
|
| Total Debt | 0.17 | 0.54 | 1.38 | 0.71 | 35.05 | Upgrade
|
| Net Cash (Debt) | 9.6 | 2.44 | 11.75 | 29.66 | -34.43 | Upgrade
|
| Net Cash Growth | 293.40% | -79.23% | -60.39% | - | - | Upgrade
|
| Net Cash Per Share | 0.03 | 0.01 | 0.06 | 0.37 | -0.49 | Upgrade
|
| Filing Date Shares Outstanding | 404 | 226.75 | 194.59 | 194.58 | 70.67 | Upgrade
|
| Total Common Shares Outstanding | 404 | 226.75 | 194.59 | 194.58 | 70.67 | Upgrade
|
| Working Capital | 6.24 | 1.26 | 11.22 | 29.58 | -34.04 | Upgrade
|
| Book Value Per Share | 0.02 | 0.01 | 0.06 | 0.15 | -0.48 | Upgrade
|
| Tangible Book Value | 6.88 | 2.09 | 11.64 | 29.66 | -33.99 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.01 | 0.06 | 0.15 | -0.48 | Upgrade
|
| Machinery | 1.21 | 0.99 | 1.95 | 1.77 | 1.69 | Upgrade
|
| Leasehold Improvements | 0.33 | 0.31 | 0.29 | 0.28 | 0.28 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.